Skip to main content

Table 3 Other parameters of clinical outcome

From: Exercise training alone or in combination with high-protein diet in patients with late onset Pompe disease: results of a cross over study

 ControlExerciseExercise + Diet
BeforeAfterp-valueBeforeAfterp-valueBeforeAfterp-value
Arms Extensors (N)105,13 ± 46,27107 ± 103,210,812546,11 ± 84,4255,36 ± 76,910,312596,86 ± 96,0287,4 ± 101,10,4609
Arms Flexors (N)104,48 ± 106,84123,38 ± 80,90,546974,8 ± 79,8864,74 ± 59,540,2597,65 ± 79,489,03 ± 78,780,1953
Legs Extensors (N)164,23 ± 111,47185,95 ± 120,070,5469136,62 ± 186,13148,5 ± 81,510,3125179 ± 199,61152,86 ± 248,10,9453
Legs Flexors (N)120,87 ± 85,2294,88 ± 74,490,937580,62 ± 79,9155,5 ± 47,260,210967,7 ± 33,8479,73 ± 60,50,3125
CK (U/L)280 ± 257279 ± 2840,2383258 ± 262371 ± 2130,4131272,5 ± 218255 ± 1040,1406
LDH (U/L)322 ± 209325 ± 2150,1367320 ± 218320 ± 2570,2012303 ± 278261,5 ± 2400,0469
6MWT (m)404 ± 93412 ± 1270,4258425 ± 151420 ± 1520,166416,8 ± 129409 ± 119,21
VC (%)70 ± 3371 ± 310,179771 ± 4271 ± 48,50,984475 ± 4289,5 ± 440,0625
FEV1 (%)70 ± 3371 ± 380,378971 ± 4272,4 ± 39,50,484466,5 ± 5385 ± 490,0391
  1. Data are expressed as median ± interquartile range before and after each intervention period
  2. 6MWT maximum walking distance measured by the 6 min walking test
  3. VC vital capacity, FEV1 forced expiratory volume in 1 s